509 related articles for article (PubMed ID: 15574767)
21. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
Feys L; Descamps B; Vanhove C; Vral A; Veldeman L; Vermeulen S; De Wagter C; Bracke M; De Wever O
Oncotarget; 2015 Sep; 6(29):26615-32. PubMed ID: 26396176
[TBL] [Abstract][Full Text] [Related]
24. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.
Yasumoto K; Koizumi K; Kawashima A; Saitoh Y; Arita Y; Shinohara K; Minami T; Nakayama T; Sakurai H; Takahashi Y; Yoshie O; Saiki I
Cancer Res; 2006 Feb; 66(4):2181-7. PubMed ID: 16489019
[TBL] [Abstract][Full Text] [Related]
25. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
Lefort S; Thuleau A; Kieffer Y; Sirven P; Bieche I; Marangoni E; Vincent-Salomon A; Mechta-Grigoriou F
Oncogene; 2017 Mar; 36(9):1211-1222. PubMed ID: 27669438
[TBL] [Abstract][Full Text] [Related]
27. Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously.
Jiang J; Shen N; Song W; Yu H; Sakurai K; Tang Z; Li G
Biomater Sci; 2019 Dec; 7(12):5283-5291. PubMed ID: 31603448
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma.
Jeong WJ; Choi IJ; Park MW; An SY; Jeon EH; Paik JH; Sung MW; Ahn SH
J Clin Pathol; 2014 Nov; 67(11):992-8. PubMed ID: 25118295
[TBL] [Abstract][Full Text] [Related]
30. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.
Wang W; Belosay A; Yang X; Hartman JA; Song H; Iwaniec UT; Turner RT; Churchwell MI; Doerge DR; Helferich WG
Clin Exp Metastasis; 2016 Jun; 33(5):475-85. PubMed ID: 27209469
[TBL] [Abstract][Full Text] [Related]
31. Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
Li J; Li T; Li S; Xie L; Yang YL; Lin Q; Kadoch O; Li H; Hou S; Xu Z
J Investig Med; 2019 Feb; 67(2):338-345. PubMed ID: 30367010
[TBL] [Abstract][Full Text] [Related]
32. PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
Lee Y; Kim SJ; Park HD; Park EH; Huang SM; Jeon SB; Kim JM; Lim DS; Koh SS
Oncogene; 2010 Jan; 29(1):56-67. PubMed ID: 19784070
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.
Cronin PA; Wang JH; Redmond HP
BMC Cancer; 2010 May; 10():225. PubMed ID: 20492653
[TBL] [Abstract][Full Text] [Related]
34. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
36. Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models.
Peng SB; Zhang X; Paul D; Kays LM; Gough W; Stewart J; Uhlik MT; Chen Q; Hui YH; Zamek-Gliszczynski MJ; Wijsman JA; Credille KM; Yan LZ
Mol Cancer Ther; 2015 Feb; 14(2):480-90. PubMed ID: 25504752
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
Ling X; Arlinghaus RB
Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
[TBL] [Abstract][Full Text] [Related]
39. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
[TBL] [Abstract][Full Text] [Related]
40. Multimodal Fluorescence and Bioluminescence Imaging Reveals Transfection Potential of Intratracheally Administered Polyplexes for Breast Cancer Lung Metastases.
Geyer A; Taschauer A; Alioglu F; Anton M; Maier J; Drothler E; Simlinger M; Yavuz S; Sami H; Ogris M
Hum Gene Ther; 2017 Dec; 28(12):1202-1213. PubMed ID: 28874076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]